Talk to users
We spoke with clinicians who routinely use bone void fillers about their needs and interest.
A global medical device company wanted to know if surgeons would value bone void fillers preloaded with antibiotics. We interviewed 31 clinicians across 6 specialties to test the need, interest and conditions for use.
The client is a global medical device company. It was running an infection control initiative across 5 product areas.
Prescouter was asked to investigate the potential benefit and added convenience of adding antimicrobials to existing bone void filling products, as part of the client’s infection control initiative.
Where infection risk drives demand.
Who would use it, and when.
Which drugs and patients fit best.
We spoke with clinicians who routinely use bone void fillers about their needs and interest.
Interviews spanned trauma, orthopedic, foot and ankle, podiatric and joint reconstructive surgery.
Partial findings came at every meeting, ending in a report and an easy-to-read interview matrix.
Prescouter gathered real-world views from 31 clinicians on the need for antimicrobial bone void fillers. The findings showed market potential, preferred antibiotics, the patient groups most likely to benefit and the conditions under which surgeons would use the product.
Grounded in clinician demand.
Named by the surgeons themselves.
Patients who benefit most.
Product ideas that sound convenient still need clinical buy-in. Talking to routine users early shows what will actually be adopted.
Talk to the clinicians who matter and build what they will use. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address